1. Home
  2. DTCX vs RFL Comparison

DTCX vs RFL Comparison

Compare DTCX & RFL Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Datacentrex Inc. Common Stock

DTCX

Datacentrex Inc. Common Stock

N/A

Current Price

$1.98

Market Cap

79.3M

Sector

Technology

ML Signal

N/A

Logo Rafael Holdings Inc. Class B

RFL

Rafael Holdings Inc. Class B

HOLD

Current Price

$1.84

Market Cap

92.6M

Sector

Finance

ML Signal

HOLD

Company Overview

Basic Information
Metric
DTCX
RFL
Founded
N/A
2017
Country
United States
United States
Employees
N/A
N/A
Industry
EDP Services
Real Estate
Sector
Technology
Finance
Exchange
Nasdaq
Nasdaq
Market Cap
79.3M
92.6M
IPO Year
2021
2017

Fundamental Metrics

Financial Performance
Metric
DTCX
RFL
Price
$1.98
$1.84
Analyst Decision
Analyst Count
0
0
Target Price
N/A
N/A
AVG Volume (30 Days)
74.9K
92.2K
Earning Date
04-13-2026
06-10-2026
Dividend Yield
N/A
N/A
EPS Growth
8.00
28.28
EPS
N/A
N/A
Revenue
$2,446.00
$917,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
N/A
N/A
P/E Ratio
N/A
N/A
Revenue Growth
N/A
43.96
52 Week Low
$1.51
$1.12
52 Week High
$3.80
$3.96

Technical Indicators

Market Signals
Indicator
DTCX
RFL
Relative Strength Index (RSI) 53.39 40.50
Support Level $1.83 $1.21
Resistance Level $2.06 $2.16
Average True Range (ATR) 0.09 0.17
MACD 0.02 -0.01
Stochastic Oscillator 71.88 17.95

Price Performance

Historical Comparison
DTCX
RFL

About DTCX Datacentrex Inc. Common Stock

Datacentrex Inc is a digital infrastructure and capital deployment company that owns and operates Scrypt compute assets and evaluates strategic transactions across asset-backed operating businesses. Its current operating platform is centered on owned and operated Scrypt-based proof-of-work compute deployed through third-party colocation facilities. Datacentrex monetizes this compute through hashrate marketplace mechanisms and manages a treasury of digital assets and cash in a manner intended to preserve capital and support opportunistic, accretive deployment. The company's operations are principally operated remotely at various data centers throughout the United States.

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.

Share on Social Networks: